Founded in 2006 by a group of Chinese Nationals trained in USA, BioHermes is committed to serve the primary care market by developing and manufacturing convenient, reliable, cost effective point-of-care tests (POCT). With a solid foundation in obstetrics and diabetes testing, BioHermes is aiming to become a long-lasting partner in supporting Women's Health and patients with Diabetes.
BioHermes has its headquarters and manufacturing facilities in Wuxi, China. The company has 48,500 square feet of manufacturing space including lab 17,000 square feet of clean room space. BioHermes continually invests into quality management and is ISO 13485 compliant. The company is authorized for manufacturing class I, II and III In-Vitro Diagnostic medical devices and products. BioHermes has also established joint R&D labs at Medical Universities and Hospitals.